Advertisement

Spine


Geron, a Menlo Park, Calif.-based medical device company, has halted the first therapy made from embryonic stem cells for spinal cord injury patients that was initiated in 2010, according to a Geron news release.

Scoliosis affects more than six million people in the United States and approximately 38,000 patients undergo spinal fusion for scoliosis correction each year, according to the National Scoliosis Foundation. Surgical scoliosis correction has traditionally been a large, open procedure, but…

Advertisement